| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Aug 22, 2016 | ANIP Ani Pharmaceuticals Inc | Przybyl Arthur | President And CEO | Sell | 37,455 | $66.97 | $2,508,361.35 | -16.3% | |
| Aug 19, 2016 | IRWD Ironwood Pharmaceuticals Inc | Consylman Gina | Chief Accounting Officer | Sell | 207 | $13.54 | $2,802.78 | -1.0% | |
| Aug 19, 2016 | AMPH Amphastar Pharmaceuticals, Inc. | Gerst Diane G. | EVP, Qa &Regulatory Affairs | Sell | 24,046 | $19.28 | $463,606.88 | -45.3% | |
| Aug 18, 2016 | AMPH Amphastar Pharmaceuticals, Inc. | Prins Richard K61 | Director | Sell | 3,086 | $19.62 | $60,539.30 | -10.6% | |
| Aug 17, 2016 | CPIX Cumberland Pharmaceuticals Inc | Lawrence Thomas R | Director | Sell | 3,000 | $4.60 | $13,800.00 | -6.2% | |
| Aug 17, 2016 | AMPH Amphastar Pharmaceuticals, Inc. | Shandell Jason B. | President And General Counsel | Sell | 5,987 | $18.86 | $112,908.83 | -2.9% | |
| Aug 17, 2016 | EGRX Eagle Pharmaceuticals, Inc. | Proquest Investments Iv, L.P. | 10% Owner | Sell | 99,795 | $61.36 | $6,123,170.01 | -0.3% | |
| Aug 16, 2016 | BCRX Biocryst Pharmaceuticals Inc | Baker Bros. Advisors LP59 | 10% Owner | Sell | 4,046,590 | $5.00 | $20,251,102.77 | -8.2% | |
| Aug 16, 2016 | AMPH Amphastar Pharmaceuticals, Inc. | Shohet Stephen B. | Director | Sell | 48,375 | $18.24 | $882,280.67 | -46.9% | |
| Aug 16, 2016 | RMTI Rockwell Medical, Inc. | Holt Kenneth L | Director | Sell | 3,692 | $7.31 | $26,991.46 | -2.0% | |
| Aug 15, 2016 | PCRX Pacira Biosciences, Inc. | Scibetta James S | President | Sell | 25,000 | $45.21 | $1,130,250.00 | -48.0% | |
| Aug 15, 2016 | SNOA Sonoma Pharmaceuticals, Inc. | Schutz James J | Chief Executive Officer | Buy | 1,328 | $3.66 | $4,865.66 | +25.7% | |
| Aug 15, 2016 | PCRX Pacira Biosciences, Inc. | Stack David M67 | CEO And Chairman | Sell | 15,000 | $45.32 | $679,800.00 | -30.8% | |
| Aug 15, 2016 | AMPH Amphastar Pharmaceuticals, Inc. | Zasloff Michael A53 | Director | Sell | 48,375 | $18.15 | $878,106.13 | -42.7% | |
| Aug 12, 2016 | LLY Eli Lilly & Co | Tai Jackson P | Director | Buy | 2,560 | $80.42 | $205,875.20 | +6.5% | |
| Aug 12, 2016 | COLL Collegium Pharmaceutical, Inc | Fallon John A. | Director | Buy | 2,375 | $10.59 | $25,151.25 | New | |
| Aug 12, 2016 | AMPH Amphastar Pharmaceuticals, Inc. | Peters William J52 | CFO, SVP &Treasurer | Sell | 1,027 | $18.19 | $18,680.72 | -1.6% | |
| Aug 12, 2016 | BCRX Biocryst Pharmaceuticals Inc | Staab Thomas R II | Senior Vice President And CFO | Sell | 5,864 | $5.18 | $30,388.06 | -2.3% | |
| Aug 11, 2016 | BHC Bausch Health Companies Inc. | Karabelas Argeris N73 | Director | Buy | 4,000 | $24.65 | $98,600.00 | +23.9% | |
| Aug 11, 2016 | LFCR Lifecore Biomedical, Inc. \de\ | Steele Gary T | Director | Sell | 34,484 | $12.47 | $429,877.54 | -34.6% | |
| Aug 11, 2016 | AMPH Amphastar Pharmaceuticals, Inc. | Shandell Jason B. | President | Sell | 5,636 | $18.01 | $101,482.38 | -2.6% | |
| Aug 11, 2016 | AMPH Amphastar Pharmaceuticals, Inc. | Prins Richard K61 | Director | Sell | 13,993 | $18.03 | $252,274.20 | -32.5% | |
| Aug 10, 2016 | MRK Merck & Co., Inc. | Golestani Clark | EVP &Chief Info Officer | Sell | 3,000 | $63.03 | $189,090.00 | -17.6% | |
| Aug 9, 2016 | BCRX Biocryst Pharmaceuticals Inc | Staab Thomas R II | Senior Vice President And CFO | Sell | 14,577 | $4.43 | $64,576.11 | -10.1% | |
| Aug 8, 2016 | ANIP Ani Pharmaceuticals Inc | Schrepfer Robert W | VP Bus Dev &Con Mfg | Sell | 12,500 | $67.06 | $838,208.75 | -41.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.